1
Bioequivalence and Pharmacokinetic Study of Prurisolâ„¢ and Abacavir Sulfate in Healthy Volunteers
Condition(s):PsoriasisLast Updated:October 26, 2018Completed
Abacavir Sulfate: 273 Clinical Trials, Page 1 of 28
Hide Studies Not Open or Pending
2
ZIAGEN® Post-marketing Surveillance
Condition(s):Infection, Human Immunodeficiency Virus ILast Updated:June 19, 2018Completed
3
Determining the Effect of Abacavir on Platelet Activation
Condition(s):HIV; Cardiovascular DiseaseLast Updated:May 22, 2015Completed
4
PENTA15: Pharmacokinetic Study of Once Versus Twice Daily Abacavir in HIV-1 Infected Children Aged 3 to <36 Months
Condition(s):HIV InfectionLast Updated:March 20, 2014Completed
5
Tenofovir Abacavir Platelet Activation Study
Condition(s):HIVLast Updated:April 11, 2018Completed
6
Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy Subjects
Condition(s):Healthy VolunteersLast Updated:February 4, 2011Completed
7
Abacavir Pharmacokinetic Study in the Absence/Presence of Darunavir/Ritonavir or Raltegravir in HIV-infected Subjects
Condition(s):HIVLast Updated:November 18, 2009Completed
8
Multicentre Study To Assess Changes In Bone Mineral Density Of The Switch From Tenofovir To Abacavir In Hiv-1-Infected Subjects With Loss Of Bone Mineral Density
Condition(s):HIVLast Updated:October 17, 2012Completed
9
Changes in Weight, Body Composition and Cardiac Risk After Discontinuing Abacavir Treatment in HIV-infected Individuals
Condition(s):Hiv; HIV Infections; HIV Cardiomyopathy; Weight Change, Body; HIV Lipodystrophy; Cardiovascular DiseasesLast Updated:May 27, 2021Unknown status
10
Abacavir and Lamivudine PK in Children
Condition(s):HIVLast Updated:February 22, 2016Completed